Michèle J. Hoffmann

3.3k citations
100 papers · 2.3k indexed · h-index 29

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Epigenetics and DNA Methylation
    • Histone Deacetylase Inhibitors Research
    • RNA modifications and cancer
    • Cancer-related gene regulation
    • Protein Degradation and Inhibitors

Papers in

    • Epigenetics and DNA Methylation 42
    • Histone Deacetylase Inhibitors Research 20
    • RNA modifications and cancer 8
    • Cancer-related gene regulation 7
    • Peptidase Inhibition and Analysis 9
    • CAR-T cell therapy research 8

Michèle J. Hoffmann

93 papers receiving 2.3k citations

Peers

Michèle J. Hoffmann
Comparison fields: 5 of 130
  • Cancer Research 536
  • Molecular Biology 1.7k
  • Oncology 487
  • Surgery 380
  • Pulmonary and Respiratory Medicine 280
Replace Juan A. Recio with:
Juan A. Recio Spain
Michael Bergqvist Sweden
Stephen Welch Canada
Yue Gong China
P. Savvides United States
Ilan Bruchim Israel
Michael Fraser Canada
Cuizhi Geng China
Lisa M. Schumaker United States
Shigetoyo Saji Japan
Michèle J. Hoffmann relative to Juan A. Recio Spain Juan A. Recio's profile →
Citations per field
00.5×4.1×
Juan A. Recio · 1×
Citations per year

Countries citing papers authored by Michèle J. Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Michèle J. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle J. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle J. Hoffmann more than expected).

Fields of papers citing papers by Michèle J. Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle J. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle J. Hoffmann. The network helps show where Michèle J. Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Michèle J. Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michèle J. Hoffmann Line = papers co-authored together Michèle J. Hoffmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20250
5 20230
6 20234
7 202340
8 202120
9 20218
10 202010
11 202025
12 20207
13 20208
14 20205
15 201920
16 201834
17 20184
18 201714
19 201511
20 201519

About Michèle J. Hoffmann

Michèle J. Hoffmann is a scholar working on Molecular Biology, Oncology, Cancer Research, Family Practice and Surgery, having authored 100 papers that have together received 2.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (42 papers), Bladder and Urothelial Cancer Treatments (30 papers), Histone Deacetylase Inhibitors Research (20 papers), Peptidase Inhibition and Analysis (9 papers), RNA modifications and cancer (8 papers), CAR-T cell therapy research (8 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Cancer Research (536 citations), Molecular Biology (1.7k citations), Oncology (487 citations), Surgery (380 citations) and Pulmonary and Respiratory Medicine (280 citations). Michèle J. Hoffmann has collaborated with scholars based in Germany, Switzerland and Hungary. Frequent co-authors include Wolfgang A. Schulz, Günter Niegisch, Rainer Engers, Maria Pinkerneil, Mirko Müller, Andrea R. Florl, Margaretha A. Skowron, Tibor Szarvas, Christiane Hader and Volker Jung. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research, Molecular Cancer and Clinical Epigenetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026